Evidence map›Paper›PMID 40313561›Full record

ArticleFrontiers in medicine2025

Performance of HPV genotyping and

Saiping Mao, Xing Fan, Li Yang, Hongtao Li, Dandan Liu, Xiaoli He, Xiaoli Wang, Fang Yu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Saiping Mao *Department of Obstetrics and Gynecology, Changsha Hospital for Maternal and Child Health Care Affiliated to Hunan Normal University, Changsha, China.
Xing Fan *Department of Obstetrics and Gynecology, Changsha Hospital for Maternal and Child Health Care Affiliated to Hunan Normal University, Changsha, China.
Li YangDepartment of Obstetrics and Gynecology, Changsha Hospital for Maternal and Child Health Care Affiliated to Hunan Normal University, Changsha, China.
Hongtao LiDepartment of Medicine, Hunan Hoomya Gene Technology Co., Ltd., Changsha, China.
Dandan LiuDepartment of Medicine, Hunan Hoomya Gene Technology Co., Ltd., Changsha, China.
Xiaoli HeDepartment of Obstetrics and Gynecology, Changsha Hospital for Maternal and Child Health Care Affiliated to Hunan Normal University, Changsha, China.
Xiaoli WangHunan Normal University, Changsha, China.
Fang YuDepartment of Obstetrics and Gynecology, Changsha Hospital for Maternal and Child Health Care Affiliated to Hunan Normal University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: High-risk human papillomavirus (HR-HPV) screening has increased colposcopy referrals, particularly for women with HR-HPV positivity but no intraepithelial lesion or malignancy (NILM) and those with atypical squamous cells of undetermined significance (ASC-US). A fraction of low-grade squamous intraepithelial lesions (LSILs) is associated with cervical intraepithelial neoplasia grade 2 or worse (CIN2+) during diagnosis. This study evaluated the ability of Methods: To improve cervical screening efficiency, risk stratification based on HPV genotyping and Results: Conclusion: HPV16/18 or

Indexed as

absolute riskcervical intraepithelial neoplasiacervical screeningGYPC methylationhigh-risk human papillomavirus

Identifiers

PMID40313561
PMCPMC12043468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.